Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age. It is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Increasing evidence suggests a strong association between PCOS, metabolic syndrome (MetS), and insulin resistance (IR). These interconnected conditions significantly increase the risk of type 2 diabetes mellitus, cardiovascular diseases, and long-term morbidity. This article aims to analyze the relationship between PCOS, metabolic syndrome, and insulin resistance by reviewing current clinical and epidemiological data. The findings highlight the importance of early screening and multidisciplinary management strategies.
Tillayeva et al. (2026) studied this question.